Key result
ZFAS1 inhibition reduces high glucose-induced ferroptosis in retinal endothelial cells via the miR-7-5p/ACSL4 axis.
Why the study?
The regulatory mechanism of lncRNA in ferroptosis related to diabetic retinopathy remains unelucidated.
Does ZFAS1 inhibition attenuate high glucose-induced ferroptosis in human retinal endothelial cells?
Does ZFAS1 inhibition attenuate high glucose-induced ferroptosis in human retinal endothelial cells?
ZFAS1 inhibition attenuates high glucose-induced ferroptosis in human retinal endothelial cells via the miR-7-5p/ACSL4 axis, identifying a potential therapeutic target for endothelial dysfunction in diabetic retinopathy.
Hypothesis-generating for diabetic retinopathy endothelial protection; requires in vivo and clinical validation before any therapeutic consideration.
Accumulating evidence has suggested the significant role of long noncoding RNAs (lncRNA) in regulating ferroptosis, while its regulatory mechanism in diabetic retinopathy (DR) remains unelucidated. In this work, we first demonstrated that lncRNA zinc finger antisense 1 (ZFAS1) is upregulated in high glucose‐cultured human retinal endothelial cells (hRECs) and ZFAS1 inhibition attenuated high glucose‐ (HG‐) induced ferroptosis, which was evidenced by cell viability, total iron and ferrous iron levels, reactive oxygen species (ROS) level, and Glutathione Peroxidase 4 (GP X 4) expression detection. Mechanistically, we validated that ZFAS1 may act as a competing endogenous RNA by competitively binding with microRNA‐7‐5p (miR‐7‐5p) and modulating the expression of its downstream molecule acyl‐CoA synthetase long‐chain family member 4 (ACSL4), which is now identified as a classic driver gene of ferroptosis process. In conclusion, our results demonstrate that HG‐induced ZFAS1 elevation activates ferroptosis in hRECs and the ZFAS1/miR‐7‐5p/ACSL4 axis may serve as a therapeutic target for endothelial dysfunction in DR.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) studied Diabetic Retinopathy. ZFAS1 inhibition was evaluated on Ferroptosis (cell viability, total iron, ferrous iron, ROS, GPX4 expression). ZFAS1 inhibition attenuated high glucose-induced ferroptosis in human retinal endothelial cells via the miR-7-5p/ACSL4 axis, suggesting a potential therapeutic target for diabetic retinopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: